Rh blood system classification and compatible blood transfusion
10.13303/j.cjbt.issn.1004-549x.2022.03.010
- VernacularTitle:Rh血型系统分型与相容性输血研究
- Author:
Yachun SUN
1
;
Hailan LI
2
;
Zhonghui GUO
3
;
Ping ZHANG
4
;
Qingbao MENG
1
Author Information
1. Shenzhen People’s Hospital, Shenzhen 518020, China
2. People’ Hospital of Guangxi Zhuang Autonomous Region
3. Guangzhou Panyu Central Hospital
4. Aikang Reagent Company Limited
- Publication Type:Journal Article
- Keywords:
Rh blood groups;
Rh phenotype;
frequency;
compatible blood transfusion
- From:
Chinese Journal of Blood Transfusion
2022;35(3):272-274
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To investigate the profiles of RhC, c, E, and e antigens and phenotypes in 4 704 inpatients from multiple regions, i. e. Nanning, Guangzhou and Shenzhen, and provide data information for compatibility blood transfusion of Rh blood group. 【Methods】 The Rh blood group antigens were detected by microcolumn gel cards from three manufactures. If the test and the control results are inconsistent, a third-party reagent would be used, and traditional tube method for confirmation if needed. The Chi-square test and Fisher's exact test were used to analyze antigen frequency and Rh phenotypes in each region. 【Results】 Among the 4 704 inpatients, the frequency of C, c, E, and e antigen was e(91.77%)>C(85.64%)>c(49.62%)>E(41.60%), and Rh phenotypes distribution was CCee(49.40%)>CcEe(27.53%)>Ccee(8.16%)>ccEE(7.74%)>ccEe(4.89%)>CCEe(0.96%)>ccee(0.83%)>CcEE(0.47%)>CCEE(0.02%). There were significant differences in Rh blood type distribution among Nanning, Guangzhou and Shenzhen(P<0.05). Differences in Rh phenotype distribution between male and female were noticed in Shenzhen(P< 0.05), but not in Nanning or Guangzhou. 【Conclusion】 The distribution of Rh blood group in Shenzhen, Nanning and Guangzhou were significantly different from each other, therefore regional characteristics should be considered when carrying out Rh-compatible blood transfusion, so as to guarantee the security of transfusion and reduce the incidence of unexpected antibodies.
